Home

Pharmacotherapy of depression in palliative patients

Repository of Nicolaus Copernicus University

Show simple item record

dc.contributor.author Trawka, Paulina
dc.contributor.author Paszkowska, Aleksandra
dc.contributor.author Lamch, Magdalena
dc.contributor.author Wijata, Aleksandra
dc.contributor.author Hejnosz, Paweł
dc.contributor.author Graczykowska, Karolina
dc.contributor.author Jabłońska, Magdalena Julia
dc.contributor.author Dorobiała, Jakub
dc.contributor.author Lazarek, Maciej
dc.contributor.author Denkiewicz, Michał
dc.contributor.author Kędziora-Kornatowska, Kornelia
dc.date.accessioned 2019-08-20T12:57:19Z
dc.date.available 2019-08-20T12:57:19Z
dc.date.issued 2019-08-20
dc.identifier.citation Journal of Education, Health and Sport, No. 9, Vol. 9, pp. 27-37
dc.identifier.issn 2391-8306
dc.identifier.other doi:10.5281/zenodo.3372330
dc.identifier.uri http://repozytorium.umk.pl/handle/item/5941
dc.description.abstract Introduction: Depression often affects people suffering from serious illnesses, including oncological and palliative patients. It reduces their quality of life and worsens their prognosis. This is why it is so important to properly treat depression in palliative patients. Material and Methods: The information provided was collected as a result of analysis of various articles and textbooks on development, diagnosis and treatment, as well as prevention of depression in terminally ill patients using Google Scholar and PubMed databases. Results: The results show that the most common drug in therapy for palliative patients with depression are the sluggish serotonin reuptake inhibitors (SSRIs). SSRIs inhibit serotonin transporter reducing serotonin reuptake. This raises the level of neurotransmitter - serotonin - in the synaptic cleft. They are well tolerated and have fewer side effects than older antidepressants (tricyclic antidepressants and monoamine oxidase inhibitors). Tricyclic antidepressants may relieve neuropathic pain and they are also beneficial for patients with insomnia. Mirtazapine in addition to antidepressant effects also causes increasing appetite, reducing nausea and sedative effect. In cancer-diagnosed patients particular attention should be paid to side effects such as nausea and vomiting that may occur in patients undergoing radiotherapy and chemotherapy using SSRIs or TCAs. SSRI therapy have a good safety profile and also interacts less frequently, while atypical antipsychotics may reduce the discomforts of taking chemotherapy. An alternative method of treating depression is the use of psychostimulants such as methylphenidate. Another way to treat depression is psychotherapy. Conclusions: There are several options for treating depression in palliative patients. It is important to pay attention to the side effects of prescribed medicines. Nevertheless, the best results are obtained by combining pharmacotherapy with psychotherapy.
dc.language.iso eng
dc.rights Attribution-NonCommercial-ShareAlike 4.0 International
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subject depression
dc.subject palliative patients
dc.subject sluggish serotonin reuptake inhibitors
dc.subject SSRI
dc.subject tricyclic antidepressants
dc.subject TCA
dc.title Pharmacotherapy of depression in palliative patients
dc.type info:eu-repo/semantics/article


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International

Search repository



Advanced Search

Browse

My Account

Statistics

Informations